Google Search
Prof. Dr.-Ing. habil. Jens Haueisen
Director of the BMTI Institute and head of Biomedical Engineering Group
Prof. Dr.-Ing. habil. Jens Haueisen
phone: +49 3677 69 2861
It is of great fundamental medical importance to be able to recognize biological toxicity reactions in cells and tissues at an early stage. Efficient and fast optical, spectroscopic, multimodal methods are a promising approach here. The project combines modern genetic methods based on CRISPR / Cas9 technology and biochemical processes with multimodal optical-spectroscopic analyzation methods (including e.g. fluorescence spectroscopy and fluorescence lifetime imaging) in order to develop an innovative data processing framework that can efficiently, quickly and specifically classify such reactions.
For this purpose, methods of artificial intelligence, such as machine learning and deep learning, are researched and adapted for multimodal optical-spectroscopic data. The results are a potential starting point for diagnostic procedures, in the development of new drugs and future medical technology devices. We expect the results of this interdisciplinary research group to provide valuable impetus for Thuringia as a location for medical technology.
Unternehmensbeirat für 2019 FGR 0083
Chair:
Members: